WHAT THE STUDY ACTUALLY SAYSAn individual-participant meta-analysis of eight trials and 5,642 women found no clinically important difference in live births whether the time-lapse add-on gave undisturbed culture, smarter selection, or both.
4 min read
WHAT THE STUDY ACTUALLY SAYSAmong privately insured patients, 63% with IVF coverage had a baby within 2.5 years versus 53% without. The gap was driven mostly by covered patients starting more cycles — not a higher success rate per cycle.
3 min read
WHAT THE STUDY ACTUALLY SAYSInjecting one sperm into each egg was meant for severe male-factor cases, yet clinics now use it widely. Pooling six randomised trials found no live-birth advantage over standard IVF when sperm is not the problem.
4 min read
WHAT THE STUDY ACTUALLY SAYSA European trial stopped early for futility: clinical pregnancy occurred in 15.7% of women given transdermal testosterone before IVF and 14.9% given placebo. The trial was funded by Ferring.
3 min read
WHAT THE STUDY ACTUALLY SAYSIn a 4,376-woman trial across 24 Chinese centres, natural-cycle embryo transfer gave the same healthy-live-birth rate as a programmed hormone regimen, with less pre-eclampsia and postpartum haemorrhage.
4 min read
EXPLAINERPopular extras like embryo genetic testing and endometrial scratching did not raise live-birth rates in their biggest randomised trials, and the UK regulator warns most patients need none of them.
3 min read
WHAT THE STUDY ACTUALLY SAYSIn two large clinics, the live birth rate per woman who returned to use her eggs was around 39-50% under 35 or 38, but far lower for older women — and most women who froze never came back to use them.
4 min read
WHAT THE STUDY ACTUALLY SAYSAn 876-participant double-blind trial across 24 Chinese fertility centres nearly doubled serum 25-OHD in women with PCOS. Live births were 52.0% against 50.2% on placebo.
4 min read